Clinical Stage Bio

Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.

Total money raised: $63M

Updated on Oct 27, 2010
Omeros at CrunchBase
Wayne Wager Director

October, 2010

Billionaire Allen helps inject $25M into Seattle's Omeros

October, 2009

Omeros IPO
Stock symbol: OMER

February, 2007

Omeros raised $63M in a Series E round from Aravis Ventures, ARCH Venture Partners, The Grosvenor Funds, Novartis Venture Fund, Southern Cross Venture Partners, Stanley Medical Research Institute, Trevi Health Ventures, and WRF Capital

Omeros Raises More Than $63 Million in Financing